The Economist2d
It’s not just AI. China’s medicines are surprising the world, too
The results were stunning. So too was the nationality of the company behind them. Akeso, a biotech firm, is Chinese.
BMJ6d
Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort
Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...
The Financial Times2y
How China aims to avoid the curse of increased longevity & ill health
The healthy China 2030 strategy Health and ageing are directly linked, of course 5, with improvements in public healthcare and medical treatment having greatly boosted human longevity. In China ...
The Financial Times3y
Bridges to health for China’s people
soaring health costs and overworked, underqualified doctors — patients often find themselves at the bottom of the pyramid. Healthy China 2030 — a state-led programme to build a healthy society ...